AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.5 Out of 5 (6634 Reviews)

KSquare’s team explained everything clearly. I never thought borrowing against my mutual funds would be this easy.

Nandini Rao

Nandini Rao

Event Coordinator

KSquare makes it simple to understand which NFO suits you. Their comparisons and insights saved me hours of research. Totally recommend it!

Vaidehi Trivedi

Vaidehi Trivedi

UX Designer

KSquare’s New Fund Offering updates are timely and insightful. I’ve participated in two NFOs already, and the results have been quite impressive and transparent.

Raghav Nair

Raghav Nair

Aviation Consultant

Thanks to KSquare’s New Fund Offering alerts, I’ve been able to catch early opportunities that matched my long-term strategy and risk appetite.

Nilesh Arora

Nilesh Arora

Sales Strategist

KSquare helped me plan my retirement with complete clarity. The SIP guidance was simple, personalised, and stress-free. I now feel financially confident about my future and family responsibilities.

Rohit Sharma

Rohit Sharma

I always tell clients about KSquare now. Their SIP system is efficient and perfectly tailored to long-term growth strategies. It’s my go-to investment tool.

Aditya Rao

Aditya Rao

Chartered Accountant

Managing money in India while living overseas used to be stressful. KSquare’s platform made everything manageable and safe.

Karan Patel

Karan Patel

Legal Consultant

It’s rare to find an investing service that explains NFOs in such a relatable way. KSquare really bridges that gap. Very impressed!

Neeti Bajoria

Neeti Bajoria

Language Trainer

The automatic deductions and growth charts at KSquare keep me informed and on track. It’s great for anyone serious about long-term financial goals.

Kunal Mishra

Kunal Mishra

Project Manager

KSquare’s approach to New Fund Offerings really impressed me. I finally feel confident participating in something I once thought was too complicated.

Lara Dhamija

Lara Dhamija

Content Editor

FAQ's

Frequenlty Asked Question

How do I track the performance of an NFO after investment?

Once listed, KSquare provides regular updates and performance tracking via your investor dashboard.

What happens if I stop my SIP before maturity?

You can withdraw your invested amount anytime. However, early exits might impact your long-term growth potential.

What is the minimum amount required to start a SIP?

You can begin a SIP with as little as ₹500 per month, making it accessible for investors of all income levels.

Which types of mutual funds are eligible for loans?

Typically, equity and debt mutual fund units held in demat form are eligible. KSquare helps confirm your fund’s eligibility instantly.

Is NPS a market-linked investment?

Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.

Can I change my fund manager in NPS via KSquare?

Yes, KSquare allows you to switch your fund manager or investment option once a year through your dashboard.

Can I pause or stop my SIP anytime with KSquare?

Yes, KSquare allows you to pause, stop, or modify your SIP plan anytime through your account dashboard.

Can I nominate someone for my NPS account?

Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.